Literature DB >> 15019946

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices.

Marina Pizzi1, Ilenia Sarnico, Flora Boroni, Marina Benarese, Michel Dreano, Gianni Garotta, Alessandra Valerio, PierFranco Spano.   

Abstract

We investigated the effects of IL-6 and a chimeric derivative of IL-6 and soluble IL-6 receptor (IL6RIL6 chimera) on excitotoxic injury in rat organotypic hippocampal slices. Brief application of N-methyl-d-aspartate (NMDA) induced astrocyte reactivity, neuron cell death, and oligodendrocyte degeneration, the latter caused by secondary activation of AMPA/kainate receptors. Both these cytokines rescued neurons and oligodendrocytes, albeit the chimeric compound was much more potent and efficient than IL-6. No change was produced on reactive astrocytosis. The cytokines preserved myelin basic protein (MBP) production in slices exposed to excitotoxic insult, and when applied singularly for a week, they also enhanced both MBP and proteolipid protein expression. These effects occurred through activating the signal transducer gp130 and were associated with stimulation of transcription factors STAT1 and STAT3. Our results suggest that IL-6 and IL6RIL6 may prove to be valuable in treating neurodegenerative and demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019946     DOI: 10.1016/j.mcn.2003.10.022

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  35 in total

1.  Markers of inflammation, vitamin E and peripheral nervous system function: the InCHIANTI study.

Authors:  Angelo Di Iorio; Antonio Cherubini; Stefano Volpato; Eleonora Sparvieri; Fulvio Lauretani; Claudio Franceschi; Umberto Senin; Giuseppe Abate; Roberto Paganelli; Antonio Martin; Cristina Andres-Lacueva; Luigi Ferrucci
Journal:  Neurobiol Aging       Date:  2005-08-22       Impact factor: 4.673

Review 2.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Authors:  Christophe Préhaud; Françoise Mégret; Mireille Lafage; Monique Lafon
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 4.  Delayed brain radiation necrosis: pathological review and new molecular targets for treatment.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Shin-Ichi Miyatake; Toshihiko Kuroiwa
Journal:  Med Mol Morphol       Date:  2015-12       Impact factor: 2.309

5.  Expression of pancreatitis-associated protein after traumatic brain injury: a mechanism potentially contributing to neuroprotection in human brain.

Authors:  Pia März-Weiss; Dieter Kunz; Daniel Bimmler; Caroline Berkemeier; Suat Özbek; Beatrice Dimitriades-Schmutz; Johannes Haybaeck; Uwe Otten; Rolf Graf
Journal:  Cell Mol Neurobiol       Date:  2011-06-05       Impact factor: 5.046

Review 6.  Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Authors:  Hong Shi; Xiaoming Hu; Rehana K Leak; Yejie Shi; Chengrui An; Jun Suenaga; Jun Chen; Yanqin Gao
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

7.  A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex.

Authors:  Jennifer J Donegan; Milena Girotti; Marc S Weinberg; David A Morilak
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 8.  Cortical spreading depression modifies components of the inflammatory cascade.

Authors:  Charlie S Thompson; Antoine M Hakim
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

9.  Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury.

Authors:  Jeannette E Davies; Christoph Pröschel; Ningzhe Zhang; Mark Noble; Margot Mayer-Pröschel; Stephen J A Davies
Journal:  J Biol       Date:  2008-09-19

Review 10.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.